Clinical trial
A Dose-finding, Safety and Tolerability Trial of Extended-release Quetiapine in Relapsing-remitting and Progressive Multiple Sclerosis
NCT02087631 is registered in ClinicalTrials.gov with University of Calgary as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Dose-finding, Safety and Tolerability Trial of Extended-release Quetiapine in Relapsing-remitting and Progressive Multiple Sclerosis
- Lead sponsor
- University of Calgary
- Phase
- Phase 1/2
- Overall status
- Completed
- Start date
- December 31, 2014
- Completion date
- July 31, 2019
- Enrollment
- 14 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.